tradingkey.logo
搜尋

Pacific Biosciences of California Inc

PACB
添加自選
1.680USD
-0.060-3.45%
收盤 07/02, 13:00美東報價延遲15分鐘
507.29M總市值
虧損本益比TTM

Pacific Biosciences of California Inc

1.680
-0.060-3.45%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-3.45%

5天

+1.82%

1月

+3.07%

6月

-8.70%

今年開始到現在

-10.16%

1年

+5.00%

關鍵數據
1.730今開
1.835最高
5.38M成交量
虧損本益比TTM
虧損本益比動
--股利TTM
1.78%換手率
1.740昨收
1.670最低
6.26M成交額
虧損本益比靜
94.84市淨率
0.00%股息率 TTM
-15.65%ROA
2.73052週最高
1.01量比
-309.85M淨利潤
301.96M總股本
-0.4133每股盈餘TTM
2.36Beta
-273.55%ROE
0.96052週最低
9.48%振幅
32.30%毛利率
507.29M總市值
1.32回報/風險
5.13%風險率

操作建議

Pacific Biosciences of California Inc當前公司基本面數據相對謹慎,增長潛力較大。當前估值合理,在醫療設備與耗材行業排名124/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為2.46。中期看,股價處於上升通道。近一個月,市場表現一般,但技術面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Pacific Biosciences of California Inc評分

相關信息

行業排名
124 / 204
全市場排名
297 / 4565
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Pacific Biosciences of California Inc亮點

亮點風險
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入160.00M美元
估值低估
公司最新PE估值-4.07,處於3年歷史低位
機構減倉
最新機構持股192.85M股,環比減少9.18%
凱西‧伍德(木頭姊姊)持倉
明星投資者凱西‧伍德(木頭姊姊)持倉,最新持倉37.12M股

分析師目標

基於 8 分析師
買入
評級
2.458
目標均價
+41.28%
漲幅空間

Pacific Biosciences of California Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Pacific Biosciences of California Inc簡介

Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
公司代碼PACB
公司Pacific Biosciences of California Inc
CEOHenry (Christian O)
網址https://www.pacb.com/

常見問題

Pacific Biosciences of California Inc(PACB)的當前股價是多少?

Pacific Biosciences of California Inc(PACB)的當前股價是 1.68。

Pacific Biosciences of California Inc 的股票代碼是什麼?

Pacific Biosciences of California Inc的股票代碼是PACB。

Pacific Biosciences of California Inc股票的52週最高點是多少?

Pacific Biosciences of California Inc股票的52週最高點是2.73。

Pacific Biosciences of California Inc股票的52週最低點是多少?

Pacific Biosciences of California Inc股票的52週最低點是0.96。

Pacific Biosciences of California Inc的市值是多少?

Pacific Biosciences of California Inc的市值是507.29M。

現在Pacific Biosciences of California Inc(PACB)的股票是買入、持有還是賣出?

根據分析師評級,Pacific Biosciences of California Inc(PACB)的總體評級為買入,目標價格為2.46。

Pacific Biosciences of California Inc(PACB)股票的每股收益(EPS TTM)是多少

Pacific Biosciences of California Inc(PACB)股票的每股收益(EPS TTM)是-1.82。